Atossa Genetics' (ATOS) ForeCYTE Breast Aspirator Not Cleared by FDA
Tweet Send to a Friend
Atossa Genetics (Nasdaq: ATOS) announced that the U.S. Food and Drug Administration has issued a determination that the ForeCYTE Breast ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
